Vera Therapeutics Inc (VERA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Marshall Fordyce
Employees:
170 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94080
650-770-0077

N/A

Data derived from most recent annual or quarterly report
Market Cap 297.751 Million Shares Outstanding20.968 Million Avg 30-day Volume 106.518 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.33
Price to Revenue0.0 Debt to Equity0.0367 EBITDA-44.73 Million
Price to Book Value4.7328 Operating Margin0.0 Enterprise Value489.491 Million
Current Ratio7.899 EPS Growth1.053 Quick Ratio7.559
1 Yr BETA 0.9697 52-week High/Low 37.11 / 12.29 Profit Margin0.0
Operating Cash Flow Growth21.9986 Altman Z-Score11.3995 Free Cash Flow to Firm -23.834 Million
Earnings Report2022-08-15

View recent insider trading info

Vera Therapeutics Inc YCharts
Yahoo! Finance finviz

Funds Holding VERA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VERA BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 4 transactions

Open Market Sells (S)

7.8 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

6.3 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CURLEY JOANNE CHIEF DEVELOPMENT OFFICER

  • Officer
 46,594 2022-06-22 4

SEIDENBERG BETH C

  • Director
 9,925 2022-05-24 1

MORRISSEY MICHAEL

  • Director
 40,000 2022-05-24 2

ENRIGHT PATRICK G

  • Director
  • 10% Owner
 9,925 2022-05-24 2

MORRISON SCOTT W

  • Director
 9,925 2022-05-24 1

KATABI MAHA

  • Director
  • 10% Owner
 9,925 2022-05-24 1

CHENG ANDREW

  • Director
 9,925 2022-05-24 1

HALL KIMBALL

  • Director
 9,925 2022-05-24 3

LIN CELIA CHIEF MEDICAL OFFICER

  • Officer
 52,412 2022-02-16 1

FORDYCE MARSHALL PRESIDENT AND CEO

  • Officer
  • Director
 176,154 2022-02-16 1

YOUNG JOSEPH R SVP, FINANCE, CHIEF ACCT OFFCR

  • Officer
 36,729 2022-02-16 1

GRANT SEAN CHIEF FINANCIAL OFFICER

  • Officer
 90,000 2022-02-16 1

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

KATABI MAHA

  • Director
  • 10% Owner
 3,181,442 2022-02-10 1

LONGITUDE CAPITAL PARTNERS IV, LLC

LONGITUDE VENTURE PARTNERS IV, L.P.

TAMMENOMS BAKKER JULIET

  • 10% Owner
 3,429,927 2022-02-10 1

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

HEALY JAMES

POWELL MICHAEL

  • 10% Owner
 2,914,776 2021-05-18 0

EMSTER KURT VON

  • Director
 2,978,059 2021-05-17 0

ABINGWORTH LLP

  • 10% Owner
 2,960,231 2021-05-13 0

COLLINS SETH

  • Director
 90,000 2011-11-08 0

MAZZULLO ANTHONY C CEO & PRESIDENT

  • Officer
 210,820 2011-09-20 0

MOYLAN ANDREW W

  • Director
 17,000 2008-06-09 0

HOLLY MICHAEL R

  • Director
 10,000 2007-01-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-23 18:49:07 -0400 2022-06-22 M 1,239 d 22,906 direct

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-23 18:49:07 -0400 2022-06-22 S 306 $15.02 d 23,688 direct yes

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-23 18:49:07 -0400 2022-06-22 S 1,239 $15.01 d 23,994 direct yes

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-23 18:49:07 -0400 2022-06-22 M 1,239 $6.37 a 25,233 direct

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 M 3,341 d 62,681 direct

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 M 1,346 d 24,145 direct

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 S 1,200 $15.05 d 23,994 direct yes -4.2194 0.0 1 -4.2194 2

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 S 3,341 $15.03 d 25,194 direct yes -4.2194 0.0 1 -4.2194 2

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 M 3,341 $2.90 a 28,535 direct -4.2194 0.0 1 -4.2194 2

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 S 1,346 $15.08 d 25,194 direct yes -4.2194 0.0 1 -4.2194 2

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-21 20:16:02 -0400 2022-06-17 M 1,346 $6.37 a 26,540 direct -4.2194 0.0 1 -4.2194 2

GRANT SEAN - Officer CHIEF FINANCIAL OFFICER by spouse's ira

2022-06-16 16:06:32 -0400 2022-06-15 P 857 $13.60 a 857 indirect 3.0891 3.0891 2 0.0 1

GRANT SEAN - Officer CHIEF FINANCIAL OFFICER by trust

2022-06-16 16:06:32 -0400 2022-06-15 P 992 $13.60 a 992 indirect 3.0891 3.0891 2 0.0 1

GRANT SEAN - Officer CHIEF FINANCIAL OFFICER by roth ira

2022-06-16 16:06:32 -0400 2022-06-15 P 335 $13.60 a 335 indirect 3.0891 3.0891 2 0.0 1

GRANT SEAN - Officer CHIEF FINANCIAL OFFICER by ira

2022-06-16 16:06:32 -0400 2022-06-15 P 2,816 $13.60 a 2,816 indirect 3.0891 3.0891 2 0.0 1

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-02 16:06:19 -0400 2022-05-31 M 400 d 25,491 direct

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-02 16:06:19 -0400 2022-05-31 S 400 $15.22 d 25,194 direct yes -4.972 -2.0308 0.0 1 -4.972 2

CURLEY JOANNE - Officer CHIEF DEVELOPMENT OFFICER

2022-06-02 16:06:19 -0400 2022-05-31 M 400 $6.37 a 25,594 direct -4.972 -2.0308 0.0 1 -4.972 2

MORRISSEY MICHAEL - Director

2022-05-25 16:18:24 -0400 2022-05-24 A 40,000 a 40,000 direct

ENRIGHT PATRICK G - Director - > 10% Owner

2022-05-26 16:13:22 -0400 2022-05-24 A 9,925 a 9,925 direct

CHENG ANDREW - Director

2022-05-26 16:14:52 -0400 2022-05-24 A 9,925 a 9,925 direct

SEIDENBERG BETH C - Director

2022-05-26 16:06:35 -0400 2022-05-24 A 9,925 a 9,925 direct

HALL KIMBALL - Director

2022-05-26 16:16:40 -0400 2022-05-24 A 9,925 a 9,925 direct

MORRISON SCOTT W - Director

2022-05-26 16:09:10 -0400 2022-05-24 A 9,925 a 9,925 direct

KATABI MAHA - Director - > 10% Owner

2022-05-26 16:11:19 -0400 2022-05-24 A 9,925 a 9,925 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VERA THERAPEUTICS INC VERA 2022-06-24 22:15:03 UTC -4.8058 6.3758 400000
VERA THERAPEUTICS INC VERA 2022-06-24 21:45:03 UTC -4.8058 6.3758 400000
VERA THERAPEUTICS INC VERA 2022-06-24 21:15:04 UTC -4.8058 6.3758 400000
VERA THERAPEUTICS INC VERA 2022-06-24 20:45:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 20:15:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 19:45:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 19:15:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 18:45:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 18:15:04 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 17:45:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 17:15:03 UTC -4.8022 6.3722 400000
VERA THERAPEUTICS INC VERA 2022-06-24 16:45:03 UTC -4.6886 6.2586 400000
VERA THERAPEUTICS INC VERA 2022-06-24 16:15:03 UTC -4.6886 6.2586 400000
VERA THERAPEUTICS INC VERA 2022-06-24 15:45:03 UTC -4.6886 6.2586 200000
VERA THERAPEUTICS INC VERA 2022-06-24 15:15:03 UTC -4.6886 6.2586 200000
VERA THERAPEUTICS INC VERA 2022-06-24 14:45:03 UTC -4.0678 5.6378 200000
VERA THERAPEUTICS INC VERA 2022-06-24 14:15:03 UTC -4.0678 5.6378 200000
VERA THERAPEUTICS INC VERA 2022-06-24 13:45:03 UTC -4.0678 5.6378 200000
VERA THERAPEUTICS INC VERA 2022-06-24 13:15:03 UTC -4.0678 5.6378 200000
VERA THERAPEUTICS INC VERA 2022-06-24 12:45:03 UTC -4.0678 5.6378 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments